Gilead, AstraZeneca and Roche Pursue Pipeline Deals Instead of Buyouts
The companies sought access to discovery technologies and experimental candidates this week rather than pursuing large-scale acquisitions of rivals or approved products.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.